Vaxcyte files 8-K on financial obligation
Vaxcyte said it filed a Form 8-K with the SEC covering direct or off-balance sheet financial obligation.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Vaxcyte Files 8K - Entry Into Definitive Agreement >PCVX
Vaxcyte Inc. (PCVX) filed a Form 8K - Entry Into a Definitive Agreement - with the U.S Securities and Exchange Commission on October 09, 2026. On October 9, 2026, Vaxcyte, Inc. ("Vaxcyte") consummated the sale and issuance of $575,000,000 aggregate principal amount of its 1.50% Convertible Senior Notes due 2032 (the "N